アレルギー用点眼薬の世界市場

◆英語タイトル:Allergy relieving Eye Drops Market (Drug Class - Antihistamines, Non-steroidal anti-Inflammatory Drugs, Vasoconstrictors; Type - Seasonal and Perennial Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Giant Papillary Conjunctivitis; Distribution Channel - Hospital Pharmacies, Retail, Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
◆商品コード:TPM-C03044
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2019年1月
◆ページ数:175
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,795 ⇒換算¥637,450見積依頼/購入/質問フォーム
Multi UserUSD8,795 ⇒換算¥967,450見積依頼/購入/質問フォーム
Global Site LicenseUSD11,795 ⇒換算¥1,297,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Transparency Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Transparency Market Researchが調査・発行した当レポートは、アレルギー用点眼薬の世界市場について調べ、アレルギー用点眼薬の世界規模、市場動向、市場環境、薬剤クラス別(抗ヒスタミン薬、非ステロイド系抗炎症薬、血管収縮薬)分析、タイプ別(季節性・通年性アレルギー性結膜炎、春季カタル、アトピー性角結膜炎、巨大乳頭性結膜炎)分析、流通経路別(院内薬局、小売薬局、オンライン薬局)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめました。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・アレルギー用点眼薬の世界市場動向
・アレルギー用点眼薬の世界市場環境
・アレルギー用点眼薬の世界市場規模
・アレルギー用点眼薬の世界市場規模:薬剤クラス別(抗ヒスタミン薬、非ステロイド系抗炎症薬、血管収縮薬)
・アレルギー用点眼薬の世界市場規模:タイプ別(季節性・通年性アレルギー性結膜炎、春季カタル、アトピー性角結膜炎、巨大乳頭性結膜炎)
・アレルギー用点眼薬の世界市場規模:流通経路別(院内薬局、小売薬局、オンライン薬局)
・アレルギー用点眼薬の世界市場:地域別市場規模・分析
・アレルギー用点眼薬の北米市場規模・予測
・アレルギー用点眼薬のアメリカ市場規模・予測
・アレルギー用点眼薬の中南米市場規模・予測
・アレルギー用点眼薬のヨーロッパ市場規模・予測
・アレルギー用点眼薬のアジア市場規模・予測
・アレルギー用点眼薬の日本市場規模・予測
・アレルギー用点眼薬の中国市場規模・予測
・アレルギー用点眼薬のインド市場規模・予測
・アレルギー用点眼薬の中東市場規模・予測
・アレルギー用点眼薬のアフリカ市場規模・予測
・競争状況・関連企業情報
【レポートの概要】

Allergy-relieving Eye Drops Market: Overview

This report analyzes the current and future scenario of the global allergy-relieving eye drops market for the period 2018 to 2026. Rise in geriatric population, increased prevalence of ocular disorders, and high unmet medical needs are likely to be major drivers of the global allergy-relieving eye drops market during the forecast period.

The allergy-relieving eye drops market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on drug class, type, distribution channel, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the allergy-relieving eye drops market.

Allergy-relieving Eye Drops Market: Key Segments

Based on drug class, the global allergy-relieving eye drops market has been segmented into antihistamines, non-steroidal anti-inflammatory drugs, vasoconstrictors, and others. The segments have been analyzed based on available drugs used for the treatment of allergic conjunctivitis. Based on type, the market has been classified into seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, giant papillary conjunctivitis, and others. In terms of distribution channel, the global allergy-relieving eye drops market has been divided into hospital pharmacies, retail, and online sales. Based on market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Allergy-relieving Eye Drops Market: Regional Outlook

In terms of region, the global allergy-relieving eye drops market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles major players operating in the global allergy-relieving eye drops market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Allergan Plc., Johnson & Johnson Services, Inc., Pfizer, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., and Santen Pharmaceutical Co., Ltd.

The global allergy-relieving eye drops market has been segmented as below:

Allergy-relieving Eye Drops Market, by Drug Class
Antihistamines
Non-steroidal anti-Inflammatory Drugs
Vasoconstrictors
Others
Allergy-relieving Eye Drops Market, by Type
Seasonal and Perennial Allergic Conjunctivitis
Vernal Keratoconjunctivitis
Atopic Keratoconjunctivitis
Giant Papillary Conjunctivitis
Others
Allergy-relieving Eye Drops Market, by Distribution Channel
Hospital Pharmacies
Retail
Online Sales
Allergy-relieving Eye Drops Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa

【レポートの目次】

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Allergy-relieving Eye Drops Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Allergy-relieving Eye Drops Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Pipeline Analysis
5.3. Regulatory Scenario by Region

6. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
6.3.1. Antihistamines
6.3.2. Non-steroidal Anti-inflammatory Drugs
6.3.3. Vasoconstrictors
6.3.4. Others
6.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Drug Class

7. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
7.3.1. Seasonal and Perennial Allergic Conjunctivitis
7.3.2. Vernal Keratoconjunctivitis
7.3.3. Atopic Keratoconjunctivitis
7.3.4. Giant Papillary Conjunctivitis
7.3.5. Others
7.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Type

8. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
8.3.1. Hospital Pharmacies
8.3.2. Retail
8.3.3. Online Sales
8.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel

9. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Allergy-relieving Eye Drops Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Allergy-relieving Eye Drops Market Attractiveness, by Country/Region

10. North America Allergy-relieving Eye Drops Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
10.2.1. Antihistamines
10.2.2. Non-steroidal Anti-inflammatory Drugs
10.2.3. Vasoconstrictors
10.2.4. Others
10.3. North America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
10.3.1. Seasonal and Perennial Allergic Conjunctivitis
10.3.2. Vernal Keratoconjunctivitis
10.3.3. Atopic Keratoconjunctivitis
10.3.4. Giant Papillary Conjunctivitis
10.3.5. Others
10.4. North America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
10.4.1. Hospital Pharmacies
10.4.2. Retail
10.4.3. Online Sales
10.5. North America Allergy-relieving Eye Drops Market Value Forecast, by Country, 2016–2026
10.5.1. US
10.5.2. Canada
10.6. North America Allergy-relieving Eye Drops Market Attractiveness Analysis
10.6.1. By Drug Class
10.6.2. By Type
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Allergy-relieving Eye Drops Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
11.2.1. Antihistamines
11.2.2. Non-steroidal Anti-inflammatory Drugs
11.2.3. Vasoconstrictors
11.2.4. Others
11.3. Europe Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
11.3.1. Seasonal and Perennial Allergic Conjunctivitis
11.3.2. Vernal Keratoconjunctivitis
11.3.3. Atopic Keratoconjunctivitis
11.3.4. Giant Papillary Conjunctivitis
11.3.5. Others
11.4. Europe Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
11.4.1. Hospital Pharmacies
11.4.2. Retail
11.4.3. Online Sales
11.5. Europe Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Allergy-relieving Eye Drops Market Attractiveness Analysis
11.6.1. By Drug Class
11.6.2. By Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region

12. Asia Pacific Allergy-relieving Eye Drops Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
12.2.1. Antihistamines
12.2.2. Non-steroidal Anti-inflammatory Drugs
12.2.3. Vasoconstrictors
12.2.4. Others
12.3. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
12.3.1. Seasonal and Perennial Allergic Conjunctivitis
12.3.2. Vernal Keratoconjunctivitis
12.3.3. Atopic Keratoconjunctivitis
12.3.4. Giant Papillary Conjunctivitis
12.3.5. Others
12.4. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
12.4.1. Hospital Pharmacies
12.4.2. Retail
12.4.3. Online Sales
12.5. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Allergy-relieving Eye Drops Market Attractiveness Analysis
12.6.1. By Drug Class
12.6.2. By Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Latin America Allergy-relieving Eye Drops Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
13.2.1. Antihistamines
13.2.2. Non-steroidal Anti-inflammatory Drugs
13.2.3. Vasoconstrictors
13.2.4. Others
13.3. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
13.3.1. Seasonal and Perennial Allergic Conjunctivitis
13.3.2. Vernal Keratoconjunctivitis
13.3.3. Atopic Keratoconjunctivitis
13.3.4. Giant Papillary Conjunctivitis
13.3.5. Others
13.4. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
13.4.1. Hospital Pharmacies
13.4.2. Retail
13.4.3. Online Sales
13.5. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Allergy-relieving Eye Drops Market Attractiveness Analysis
13.6.1. By Drug Class
13.6.2. By Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region

14. Middle East & Africa Allergy-relieving Eye Drops Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
14.2.1. Antihistamines
14.2.2. Non-steroidal Anti-inflammatory Drugs
14.2.3. Vasoconstrictors
14.2.4. Others
14.3. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
14.3.1. Seasonal and Perennial Allergic Conjunctivitis
14.3.2. Vernal Keratoconjunctivitis
14.3.3. Atopic Keratoconjunctivitis
14.3.4. Giant Papillary Conjunctivitis
14.3.5. Others
14.4. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
14.4.1. Hospital Pharmacies
14.4.2. Retail
14.4.3. Online Sales
14.5. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region 2016–2026
14.5.1. GCC Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness Analysis
14.6.1. By Drug Class
14.6.2. By Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1. Global Allergy-relieving Eye Drops Market Share Analysis, by Company (2016)
15.2. Company Profiles
15.2.1. Allergan plc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. SWOT Analysis
15.2.1.4. Financial Overview
15.2.1.5. Strategic Overview
15.2.2. Novartis AG
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. SWOT Analysis
15.2.2.4. Financial Overview
15.2.2.5. Strategic Overview
15.2.3. Johnson & Johnson Services, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. SWOT Analysis
15.2.3.4. Financial Overview
15.2.3.5. Strategic Overview
15.2.4. Pfizer, Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. SWOT Analysis
15.2.4.4. Financial Overview
15.2.4.5. Strategic Overview
15.2.5. F. Hoffmann-La Roche Ltd.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. SWOT Analysis
15.2.5.4. Financial Overview
15.2.5.5. Strategic Overview
15.2.6. Bausch Health Companies Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. SWOT Analysis
15.2.6.4. Financial Overview
15.2.6.5. Strategic Overview
15.2.7. Regeneron Pharmaceuticals, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. SWOT Analysis
15.2.7.4. Financial Overview
15.2.7.5. Strategic Overview
15.2.8. Santen Pharmaceutical Co., Ltd.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. SWOT Analysis
15.2.8.4. Financial Overview
15.2.8.5. Strategic Overview

List of Tables

Table 01: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 02: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 03: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 04: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 07: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 08: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 09: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 10: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 11: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 12: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 13: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 15: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 16: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 17: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 18: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 19: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 20: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 21: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 23: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 24: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026

List of Figures

Figure 01: Global Allergy-relieving Eye Drops Market Value (US$ Mn) and Distribution, by Region, 2018 and 2026
Figure 02: Global Allergy-relieving Eye Drops Market Revenue, by Drug Class, 2018(E)
Figure 04: Global Allergy-relieving Eye Drops Market Revenue Share
Figure 05: Global Allergy-relieving Eye Drops Market Revenue Share
Figure 06: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 07: Global Allergy-relieving Eye Drops Market Value Share, by Type (2017)
Figure 08: Global Allergy-relieving Eye Drops Market Value Share, by Distribution Channel (2017)
Figure 09: Global Allergy-relieving Eye Drops Market Value Share, by Region (2017)
Figure 10: Global Allergy-relieving Eye Drops Market Value Share Analysis, by Drug Class, 2018 and 2026
Figure 11: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Antihistamines, 2016–2026
Figure 12: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Non-steroidal Anti-inflammatory Drugs, 2016–2026
Figure 13: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vasoconstrictors, 2016–2026
Figure 14: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 15: Global Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 16: Global Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 17: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Seasonal and Perennial Allergic Conjunctivitis, 2016–2026
Figure 18: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vernal Keratoconjunctivitis, 2016–2026
Figure 19: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Atopic Keratoconjunctivitis, 2016–2026
Figure 20: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Giant Papillary Conjunctivitis, 2016–2026
Figure 21: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 22: Global Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 23: Global Allergy-relieving Eye Drops Market Value Share Analysis, by Distribution Channel, 2018 and 2026
Figure 24: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2016–2026
Figure 25: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail, 2016–2026
Figure 26: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Sales, 2016–2026
Figure 27: Global Allergy-relieving Eye Drops Market Attractiveness Analysis, by Distribution Channel
Figure 28: Global Allergy-relieving Eye Drops Market Value Share (%), by Region, 2018 and 2026
Figure 29: Global Allergy-relieving Eye Drops Market Attractiveness, by Region, 2018–2026
Figure 30: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 31: North America Allergy-relieving Eye Drops Market Attractiveness, by Country, 2018–2026
Figure 32: North America Allergy-relieving Eye Drops Market Value Share, by Country, 2017 and 2026
Figure 33: North America Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
Figure 34: North America Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 35: North America Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 36: North America Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 37: North America Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 38: North America Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 39: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 40: Europe Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-Region, 2018–2026
Figure 41: Europe Allergy-relieving Eye Drops Market Value Share, by Country/Sub-Region, 2017 and 2026
Figure 42: Europe Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
Figure 43: Europe Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 44: Europe Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 45: Europe Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 46: Europe Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 47: Europe Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 48: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 49: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 50: Asia Pacific Allergy-relieving Eye Drops Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 51: Asia Pacific Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
Figure 52: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 53: Asia Pacific Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 54: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 55: Asia Pacific Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 56: Asia Pacific Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 57: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 58: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 59: Latin America Allergy-relieving Eye Drops Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 60: Latin America Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
Figure 61: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 62: Latin America Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 63: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 64: Latin America Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 65: Latin America Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 66: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 67: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-Region, 2018–2026
Figure 68: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Country/Sub-Region, 2017 and 2026
Figure 69: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Drug Class, 2017 and 2026
Figure 70: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Drug Class, 2018–2026
Figure 71: Middle East & Africa Allergy-relieving Eye Drops Market Value Share Analysis, by Type, 2017 and 2026
Figure 72: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Type, 2018–2026
Figure 73: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Distribution Channel, 2017 and 2026
Figure 74: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel, 2018–2026
Figure 75: Allergan plc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
Figure 76: Allergen plc. R&D Expenses (USD Mn), 2016–2017
Figure 77: Allergan plc. Sales and Marketing Expenses (USD Mn), 2017
Figure 78: Allergan plc. Breakdown of Net Sales, by Business Segment, 2017
Figure 79 : Johnson & Johnson Services, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
Figure 80: Johnson & Johnson Services, Inc. Vision care revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2017
Figure 81: Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Business Segment, 2017
Figure 82: Johnson & Johnson Services, Inc.(Research & Development Cost, 2015 – 2017 (US$ Bn)
Figure 83: Pfizer, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 84: Pfizer, Inc. R&D Expenses and SI&A Expenses (%) 2015–2017
Figure 85: Pfizer, Inc. Breakdown of Net Sales, by Geography (Essential Health Segment), 2017
Figure 86: Pfizer, Inc. Breakdown of Net Sales, by Business Segments (%), 2017
Figure 87: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Business Segment, 2017
Figure 88: F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
Figure 89: F. Hoffmann-La Roche Ltd. Research & Development Cost, 2015 – 2017 (US$ Bn)
Figure 90: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 91: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 92: Novartis AG Breakdown of Net Sales, by Region, 2017
Figure 93: Novartis AG Breakdown of Net Sales, by Business Segments, 2017
Figure 94: Bausch Health Companies Inc. Breakdown of Net Sales (%), by Region, 2017
Figure 95: Bausch Health Companies Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
Figure 96: Bausch Health Companies Inc. Breakdown of Revenues(%), by Product Category, 2017
Figure 97: Bausch Health Companies Inc. R&D Expenses (US$ Mn), 2015-2017
Figure 98: Regeneron Pharmaceuticals, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 99: Regeneron Pharmaceuticals, Inc. R&D Expenses (US$ Mn), 2013-2017
Figure 100: Santen Pharmaceutical Co., Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
Figure 101: Santen Pharmaceutical Co., Ltd. Breakdown of Net Sales, by Operating Segments, 2017
Figure 102: Santen Pharmaceutical Co., Ltd. Breakdown of Net Sales, by Region, 2017
Figure 103: Santen Pharmaceutical Co., Ltd. Research & Development Cost, 2015–2017 (US$ Mn)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アレルギー用点眼薬の世界市場]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆